Perrigo Co PLC (PRGO)
43.29
-0.13 -0.30%
NYSE
Jan 22, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 5.097B |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | -0.06 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | -6.60M |
Profitability | |
Gross Profit Margin (Quarterly) | 35.27% |
Profit Margin (Quarterly) | -12.74% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 2.08% |
Price and Valuation | |
Market Cap | 5.909B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 1.164 |
PE Ratio | -- |
Price to Book Value | 1.015 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.6117 |
Free Cash Flow (Quarterly) | 18.90M |
Return on Equity | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
Yahoo01/19 13:29
-
PR Newswire01/11 08:00
-
Yahoo01/11 06:50
-
Yahoo01/10 10:43
-
MT Newswires01/06 08:40
-
PR Newswire12/17 08:03
-
Yahoo12/10 09:40
-
Yahoo12/07 10:56
-
Yahoo12/06 08:10
-
Yahoo12/04 11:31
-
PR Newswire11/17 08:15
-
Globe Newswire11/12 07:05
-
Yahoo11/12 07:05
-
Yahoo11/12 07:02
-
Yahoo11/09 13:02
-
Yahoo11/05 15:48
-
SA Breaking News11/05 11:59
-
Yahoo11/05 09:37
-
Yahoo11/05 06:14
-
MT Newswires11/05 02:45
View All Events
Events
Date | Type | Description |
---|---|---|
02/26/2021 | Earnings | Perrigo Co PLC Fourth Quarter Earnings for 2020 Release |
02/26/2021 08:30 EST | Misc | Perrigo Co PLC Fourth Quarter Earnings Conference Call for 2020 |
11/25/2020 | Dividends | Amount: 0.225, Declared Date: Oct 22 2020, Pay Date: Dec 15 2020 |
11/04/2020 | Earnings | Perrigo Co PLC Third Quarter Earnings Result for 2020 |
11/04/2020 16:30 EST | Misc | Perrigo Co PLC Third Quarter Earnings Conference Call for 2020 |
08/27/2020 | Dividends | Amount: 0.225, Declared Date: Jul 29 2020, Pay Date: Sep 15 2020 |
08/05/2020 09:00 EDT | Misc | Perrigo Co PLC Second Quarter Earnings Conference Call for 2020 |
08/05/2020 | Earnings | Perrigo Co PLC Second Quarter Earnings Result for 2020 |
05/28/2020 | Dividends | Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020 |
05/06/2020 11:30 IST | Misc | Perrigo Co PLC Annual General Meeting for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Value
- Next Earnings Release: Feb. 26, 2021
- Last Earnings Release: Nov. 04, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 25, 2020
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to OTC and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 43.29 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
XPH | SPDR® S&P Pharmaceuticals ETF | 3.72% |
FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.37% |
SSHVX | Sound Shore Institutional | 3.23% |
CSINX | Centerstone International C | 2.82% |
TMCTX | Touchstone Mid Cap Z | 2.37% |
PILL | Direxion Daily Phrmctcl&MdclBl3XShrsETF | 2.24% |
IHE | iShares US Pharmaceuticals ETF | 2.10% |
CENNX | Centerstone Investors C | 2.07% |
PPH | VanEck Vectors Pharmaceutical ETF | 2.05% |
GRX | Gabelli Health & Wellness | 1.60% |
FPHAX | Fidelity® Select Pharmaceuticals Port | 1.31% |
DTMVX | DFA Tax-Managed US Targeted Value | 0.43% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement